| 1 |
Expanded Disability Status Scale
(3661 times)
|
Neurology
(1964 times)
|
MS (2359 times)
RRMS (549 times)
MRI (400 times)
|
1983 Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).
|
| 2 |
environmental decision support system
(10 times)
|
Environmental Health
(10 times)
|
DWTPs (2 times)
MLP (2 times)
MLR (2 times)
|
2001 Review of Expert System (ES), Geographic Information System (GIS), Decision Support System (DSS), and their applications in landfill design and management.
|
| 3 |
endolymphatic sac drainage and steroid-instillation surgery
(9 times)
|
Otolaryngology
(6 times)
|
EDRW (1 time)
ENG (1 time)
GM (1 time)
|
2001 [Vestibular symptoms and ENG findings during periods of convalescence after endolymphatic sac drainage and steroid-instillation surgery (EDSS)].
|
| 4 |
electronic decision support systems
(8 times)
|
Medicine
(3 times)
|
SMART (2 times)
AIIMS (1 time)
Algo (1 time)
|
2007 Are we measuring the right end-points? Variables that affect the impact of computerised decision support on patient outcomes: a systematic review.
|
| 5 |
Expanded Disease Status Scale
(7 times)
|
Neurology
(3 times)
|
MS (4 times)
9HPT (1 time)
AHSCT (1 time)
|
2016 Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation.
|
| 6 |
Expanded Disease Severity Scale
(4 times)
|
Health Services
(2 times)
|
MS (3 times)
DMTs (1 time)
ESSA (1 time)
|
2015 Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis.
|
| 7 |
expanded Kurtzke Disability Status Scale
(3 times)
|
Neurology
(2 times)
|
HEP (1 time)
MS (1 time)
NMES (1 time)
|
1991 Treatment of multiple sclerosis with hyperbaric oxygen. Results of a national registry.
|
| 8 |
ectodermal dysplasia-syndactyly syndrome
(2 times)
|
Genetics, Medical
(1 time)
|
EDs (1 time)
|
2010 Mutations in PVRL4, encoding cell adhesion molecule nectin-4, cause ectodermal dysplasia-syndactyly syndrome.
|
| 9 |
expanded disease disability score
(2 times)
|
Multiple Sclerosis
(1 time)
|
MS (2 times)
CLU (1 time)
CSF (1 time)
|
2021 Ultrasensitive immunoassay allows measurement of serum neurofilament heavy in multiple sclerosis.
|
| 10 |
expanded DSS
(2 times)
|
Neurology
(1 time)
|
DSS (2 times)
MS (2 times)
CP (1 time)
|
1994 Clinical definition for multiple sclerosis treatment trials.
|
| 11 |
expert decision support system
(2 times)
|
Environmental Health
(2 times)
|
BVI (2 times)
EnvRI (2 times)
GTI (1 time)
|
2008 A "weight of evidence" approach for the integration of environmental "triad" data to assess ecological risk and biological vulnerability.
|
| 12 |
neurological disability score
(2 times)
|
Vascular Diseases
(1 time)
|
CCSVI (1 time)
CDU (1 time)
IJVs (1 time)
|
2014 Venous Hemodynamic Insufficiency Severity Score variation after endovascular treatment of chronic cerebrospinal venous insufficiency.
|
| 13 |
anti-EBV VCA IgG levels, higher disability
(1 time)
|
Allergy and Immunology
(1 time)
|
BPF (1 time)
EA (1 time)
EBNA (1 time)
|
2009 Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.
|
| 14 |
each consultation; disability assessment
(1 time)
|
|
ARR (1 time)
RRMS (1 time)
|
2022 Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study.
|
| 15 |
EDA patients progressed
(1 time)
|
Medicine
(1 time)
|
EDA (1 time)
GM (1 time)
HC (1 time)
|
2015 A Longitudinal Study of Disability, Cognition and Gray Matter Atrophy in Early Multiple Sclerosis Patients According to Evidence of Disease Activity.
|
| 16 |
EDSS-S group
(1 time)
|
Allergy and Immunology
(1 time)
|
DMT (1 time)
MS (1 time)
PML (1 time)
|
2021 Disease-modifying therapies and progressive multifocal leukoencephalopathy in multiple sclerosis: A systematic review and meta-analysis.
|
| 17 |
EDSSSev
(1 time)
|
Multiple Sclerosis
(1 time)
|
2MWT (1 time)
CRI (1 time)
MS (1 time)
|
2022 Evaluation of functional outcome measures after fampridine treatment in patients with multiple sclerosis - An interventional follow-up study.
|
| 18 |
EF, but that relationship was not mediated by physical disabilities
(1 time)
|
Pain
(1 time)
|
EF (1 time)
MS (1 time)
|
2021 Pain, cognition and disability in advanced multiple sclerosis.
|
| 19 |
effect on the clinical disability scale
(1 time)
|
Neurology
(1 time)
|
---
|
1996 Immunomodulation with linomide: possible novel therapy for multiple sclerosis.
|
| 20 |
effects of the level of IFN- alpha on disability
(1 time)
|
Allergy and Immunology
(1 time)
|
IFN-alpha (1 time)
MS (1 time)
NMO (1 time)
|
2013 Interferon alpha association with neuromyelitis optica.
|
| 21 |
electron donor sufficient system
(1 time)
|
Biomedical Engineering
(1 time)
|
EDLS (1 time)
|
2023 New insights into hexavalent chromium exposure in electron donor limited denitrification: bio-electron behavior.
|
| 22 |
ELISA and correlations with clinical
(1 time)
|
Neurology
(1 time)
|
IFNbeta (1 time)
MMP-9 (1 time)
MRI (1 time)
|
2003 Serum gelatinase B/MMP-9 in primary progressive multiple sclerosis patients treated with interferon-beta-1a.
|
| 23 |
emergency department septic screening
(1 time)
|
Emergency Medical Services
(1 time)
|
CSF (1 time)
RSV (1 time)
SBI (1 time)
|
2010 Emergency Department Septic Screening in Respiratory Syncytial Virus (RSV) and Non-RSV Bronchiolitis.
|
| 24 |
emodin combined with DSS
(1 time)
|
Allergy and Immunology
(1 time)
|
DSS (1 time)
IL-1beta (1 time)
MDA (1 time)
|
2010 Protective effects of emodin combined with danshensu on experimental severe acute pancreatitis.
|
| 25 |
enhanced dengue surveillance system
(1 time)
|
Tropical Medicine
(1 time)
|
PDSS (1 time)
|
2018 Estimating dengue under-reporting in Puerto Rico using a multiplier model.
|
| 26 |
enzymatic calorimetric method.Expanded disability status scale
(1 time)
|
Complementary Therapies
(1 time)
|
UA (1 time)
|
2015 [Serum uric acid level and clinical relevance analysis in autoimmune myelopathy].
|
| 27 |
episode and Kurtzke scale
(1 time)
|
Neurology
(1 time)
|
---
|
2000 [A study of various scales of fatigue and impact on the quality of life among patients with multiple sclerosis].
|
| 28 |
Epworth Daytime Sleepiness Scale
(1 time)
|
Neuropsychology
(1 time)
|
BA (1 time)
BD (1 time)
PSQI (1 time)
|
2021 The Effect of Sleep Hygiene and Sleep Deterioration on Quality of Life in Shiftworking Healthcare Professionals.
|
| 29 |
Erectile Dysfunction Symptom Score
(1 time)
|
Sexual Dysfunction, Physiological
(1 time)
|
RP (1 time)
|
2012 Neurophysiological testing to assess penile sensory nerve damage after radical prostatectomy.
|
| 30 |
ESS, FSS, and MS disability
(1 time)
|
Diagnostic Imaging
(1 time)
|
ESS (1 time)
FSS (1 time)
MGCIPL (1 time)
|
2022 Restless legs syndrome in multiple sclerosis is related to retinal thinning.
|
| 31 |
evaluating disability worsening, cognition, and quality of life
(1 time)
|
Multiple Sclerosis
(1 time)
|
DMT (1 time)
MS (1 time)
MusiQoL (1 time)
|
2018 Patient-reported outcomes in patients with relapsing forms of MS switching to teriflunomide from other disease-modifying therapies: Results from the global Phase 4 Teri-PRO study in routine clinical practice.
|
| 32 |
event-related potential as compared to the clinical course
(1 time)
|
Medicine
(1 time)
|
---
|
2007 Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study.
|
| 33 |
examination and assessment of the Disability Status Scale
(1 time)
|
Natural Science Disciplines
(1 time)
|
MS (1 time)
RRMS (1 time)
|
2023 Multiple sclerosis diagnostic delay and its associated factors in Upper Egyptian patients.
|
| 34 |
expanded disease status score
(1 time)
|
Neurology
(1 time)
|
MSSS (1 time)
|
2009 The multiple sclerosis severity score (MSSS) predicts disease severity over time.
|
| 35 |
Expanded Standard Disability Stated Scale
(1 time)
|
Allergy and Immunology
(1 time)
|
ELISA (1 time)
IL-17A (1 time)
IL-17F (1 time)
|
2015 The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels.
|
| 36 |
extinction to tactile double simultaneous stimuli
(1 time)
|
Psychology
(1 time)
|
---
|
2008 Functional MRI of the primary somatosensory cortex in extinction to simultaneous bilateral tactile stimuli due to right temporal lobe stroke.
|
| 37 |
extradimensional strategy set-shifting
(1 time)
|
Neurology
(1 time)
|
---
|
2012 Serotonin transporter knockout rats show improved strategy set-shifting and reduced latent inhibition.
|
| 38 |
Kurtzke disability status scale
(1 time)
|
Neurology
(1 time)
|
MS (1 time)
|
2009 [A case-control study of the influence of the smoking behaviour in multiple sclerosis].
|
| 39 |
LincR-Epas1-3'AS fold change are correlated to MS severity
(1 time)
|
Neurology
(1 time)
|
MS (1 time)
TH1 (1 time)
TH2 (1 time)
|
2019 Correlation between LincR-Gng2-5'and LincR-Epas1-3'as with the severity of multiple sclerosis in Egyptian patients.
|
| 40 |
mean disability score
(1 time)
|
Neurology
(1 time)
|
---
|
1992 Early prognostic factors for disability in multiple sclerosis, a European multicenter study.
|
| 41 |
MS-related disability status
(1 time)
|
Vascular Diseases
(1 time)
|
CCSVI (1 time)
CDU (1 time)
IJVs (1 time)
|
2014 Venous Hemodynamic Insufficiency Severity Score variation after endovascular treatment of chronic cerebrospinal venous insufficiency.
|
| 42 |
Neurostatus-Expanded Disease Disability Score
(1 time)
|
|
HC (1 time)
MSFC (1 time)
PwMS (1 time)
|
2020 Visual Feedback and Postural Control in Multiple Sclerosis.
|
| 43 |
recorded disability score
(1 time)
|
Brain
(1 time)
|
AUC (1 time)
CIs (1 time)
|
2020 Early clinical markers of aggressive multiple sclerosis.
|
| 44 |
regards disease severity
(1 time)
|
Neurology
(1 time)
|
MS (1 time)
TH1 (1 time)
TH2 (1 time)
|
2019 Correlation between LincR-Gng2-5'and LincR-Epas1-3'as with the severity of multiple sclerosis in Egyptian patients.
|
| 45 |
Sclerosis Disability Scale
(1 time)
|
Otolaryngology
(1 time)
|
---
|
2018 Multiple sclerosis: Left advantage for auditory laterality in dichotic tests of central auditory processing and relationship of psychoacoustic tests with the Multiple Sclerosis Disability Scale-EDSS.
|
| 46 |
worse disease severity
(1 time)
|
Neurology
(1 time)
|
MS (1 time)
PROs (1 time)
|
2013 No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50.
|
A Search Service for Abbreviation / Long Form